Compounds > n-n--dodecane-1-12-diyl-bis-3-picolinium-dibromide

n-n--dodecane-1-12-diyl-bis-3-picolinium-dibromide and Tobacco-Use-Disorder

n-n--dodecane-1-12-diyl-bis-3-picolinium-dibromide has been researched along with Tobacco-Use-Disorder* in 2 studies

Reviews

1 review(s) available for n-n--dodecane-1-12-diyl-bis-3-picolinium-dibromide and Tobacco-Use-Disorder

ArticleYear
Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:1

    Topics: Animals; Dopamine; Drug Delivery Systems; Humans; Mice; Nicotinic Antagonists; Picolines; Rats; Recurrence; Tobacco Use Disorder

2009

Other Studies

1 other study(ies) available for n-n--dodecane-1-12-diyl-bis-3-picolinium-dibromide and Tobacco-Use-Disorder

ArticleYear
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
    Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 2009, Volume: 55

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzazepines; Brain; Bupropion; Dopamine; Dose-Response Relationship, Drug; Drugs, Investigational; Male; Neurons; Nicotine; Nicotinic Antagonists; Picolines; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Nicotinic; Reward; Smoking Cessation; Structure-Activity Relationship; Tobacco Use Disorder; Varenicline; Ventral Tegmental Area

2009